Device Trial Radar · NCT04968847
FemaSeed LOCAL Artificial Insemination Trial
Last checked: Nov 19, 2026Latest source record: Nov 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
314
Actual
Start
Jul 15, 2021
Primary completion
Dec 31, 2023
Study completion Apr 30, 2024
Sponsor
- Lead sponsor
- Femasys Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 20, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 19 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Brief Summary: The objectives of the trial are to evaluate the safety and effectiveness of the FemaSeed Localized Directional Insemination for artificial insemination, now known as the FemaSeed Intratubal Insemination since FDA Cleared under K231730 in September 2023.
Conditions
- Infertility
- Male Factor
Interventions
FemaSeed Localized Directional InseminationDevice
Subjects undergoing FemaSeed Artificial Insemination
Primary outcomes
What the sponsor says the trial is designed to measure.
- Confirmed pregnancy rate at approximately 3 weeks following FemaSeed procedure.Time frame: 3 weeks
- Primary Safety: Occurrence of ectopic pregnancy per cycleTime frame: 7 weeks
- Primary Safety: Occurrence of uterine perforation per cycleTime frame: At time of procedure
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Elite IVF, PLLC
Mobile, Alabama
Reproductive Associates of Delaware (RAD Fertility)
Newark, Delaware
Women's Medical Research Group, LLC
Clearwater, Florida
15 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.